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Drug designParasites have developed a variety of physiological functions necessary for completing at least part of their life
cycles in the specialized environments of surrounding the parasites in the host. Regarding energy metabolism,
which is essential for survival, parasites adapt to the low oxygen environment in mammalian hosts by using
metabolic systems that are very different from those of the hosts. In many cases, the parasite employs aerobic
metabolism during the free-living stage outside the host but undergoesmajor changes in developmental control
and environmental adaptation to switch to anaerobic energy metabolism. Parasite mitochondria play diverse
roles in their energymetabolism, and in recent studies of the parasitic nematode, Ascaris suum, themitochondrial
complex II plays an important role in anaerobic energy metabolism of parasites inhabiting hosts by acting as
a quinol-fumarate reductase. In Trypanosomes, parasite complex II has been found to have a novel function
and structure. Complex II of Trypanosoma cruzi is an unusual supramolecular complex with a heterodimeric
iron–sulfur subunit and seven additional non-catalytic subunits. The enzyme shows reduced binding afﬁnities
for both substrates and inhibitors. Interestingly, this structural organization is conserved in all trypanosomatids.
Since the properties of complex II differ across a wide range of parasites, this complex is a potential target for the
development of new chemotherapeutic agents. In this regard, structural information on the target enzyme is
essential for the molecular design of drugs. This article is part of a Special Issue entitled: Respiratory complex II:
Role in cellular physiology and disease.
© 2013 Published by Elsevier B.V.1. Introduction
1.1. Molecular parasitology
Parasites are classiﬁed generally as either helminths or protozoans.
Helminths are multi-cellular parasites and are divided into three types:
nematodes (e.g., Ascaris suum), trematodes (e.g., Schistosoma japonica),
and cestodes (e.g.,Diphyllobothrium latum). Protozoans include unicellu-
lar parasites (e.g., malaria parasites and Entamoeba histolytica), but
they differ from bacteria in that they have a nucleus, mitochondria,
vacuole, and other organelles (e.g., apicoplast, hydrogenosomes, andxykinase; RQ, rhodoquinone;
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sevier B.V.mitosomes). These parasites are capable of surviving and proliferating
due to avoidance of host defense mechanisms and development of
metabolic pathways adapted to the specialized environments of the
host [see reviews 1–5].
Studies of parasitic adaptation have yielded extremely informative
biological discoveries and data that are potentially useful for developing
treatments of infectious diseases. Recent advances in biochemistry
and molecular biology have provided new insights into basic parasite
biology and have led to many revolutionary discoveries concerning
biological evolution and diversity. Taken together, a new ﬁeld called
‘molecular parasitology’ is being established to investigate parasitism
at the molecular level. The unique features of parasite complex II
have been revealed through data obtained through such a pioneering
sciences [1,4,5].
1.2. Functional and subunit changes of complex II during the A. suum
life cycle
The nematode A. suum has been studied extensively as a representa-
tive of human and livestock parasites [1]. During its life cycle, A. suum
transitions from aerobic to anaerobic metabolism, reﬂecting the change
in the environmental oxygen concentration (Fig. 1) [2–7]. During devel-
opment from a fertilized egg to third stage larvae (L3) outside of the
host, metabolism is aerobic as the tissues of mammalian host in that
ATP is synthesized by aerobic oxidative phosphorylation [8]. In contrast,
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bic phosphoenolpyruvate carboxykinase (PEPCK)-succinate pathway.
The last step of the PEPCK-succinate pathway involves the NADH-
fumarate reductase system, which is composed of complex I (NADH-
quinone reductase), low-potential rhodoquinone (RQ), and complex II
(quinol-fumarate reductase, QFR) [4,9]. Electron transfer from NADH
to fumarate is coupled to ATP synthesis by site I phosphorylation in
complex I. The difference in redox potential between NAD+/NADH
(Em'=−320 mV) and fumarate/succinate (Em'=+30 mV) is sufﬁ-
cient to drive ATP synthesis [4].
In eukaryotes, complex II is localized in the inner mitochondrial
membrane and is generally composed of four peptides [4]. The largest
ﬂavoprotein (Fp, SDHA) subunit has a molecular mass of about
70 kDa and contains ﬂavin adenine dinucleotide (FAD) as a prosthetic
group. The relatively hydrophilic catalytic region of complex II is formed
by the Fp subunit and the iron–sulfur cluster (Ip, SDHB) subunit, which
has a molecular weight of about 30 kDa. The remaining subunits com-
prise cytochrome b, which contains heme b. Cytochrome b is composed
of 2 hydrophobic membrane-anchoring polypeptide subunits: the
15 kDa large subunit (CybL, SDHC) and the 13 kDa small subunit
(CybS, SDHD). These cytochrome b subunits are necessary for the inter-
action between complex II and hydrophobic membrane-associated
quinones, such as ubiquinone (UQ) and RQ [6].
In a previous study, we showed that A. suummitochondria express
stage-speciﬁc isoforms of complex II [6,7,10]. While there are no
differences in the isoforms of the Ip and CybL subunits of complex II
between L3 larvae and adult A. suum, there are different isoforms of
the complex II subunits Fp (larval, FpL; adult, FpA) and CybS (larval,
CybSL; adult, CybSA) [7]. Quinone species in the mitochondria also
differ during the life cycle of A. suum. In the adult mitochondria, the
predominant quinone is the low-potential RQ (Em’=−63 mV); in
larvae, the predominant quinone is UQ (Em’=+110 mV) [11].
Similarly, Escherichia coli and other bacteria show shifts in the combina-
tion of succinate-ubiquinone reductase (SQR) and UQ, and that of QFR
and a low-potential quinone, such as menaquinone (MK) or RQ, during
metabolic adaptation to changes in oxygen supply [12,13]. UQ has a
higher redox potential than RQ; therefore, RQ is better suited to trans-
ferring electrons to fumarate than is UQ. In L2 and L3 A. suum larvae,Fig. 1. Life cycle of A. suum. Fertilized eggs grow to infective L3 under an aerobic environmen
Afterwards, larvae migrate into the host body (liver, heart, lung, and pharynx), and ﬁnally m
oxygen concentration is only 2.5% to 5% of that of the exogenous environment. During the
mixed-type and adult-type [15].UQ preferentially donates electrons to the cytochrome chain in the
mitochondria. Thus, UQ participates in aerobic metabolism in A. suum
larvae, whereas RQ participates in anaerobic metabolism in adult
A. suum [11].
After being ingested by the deﬁnitive host, the L3 larvae penetrate
the intestinal wall and reach the lung by migrating through other
tissues, such as liver and heart. The L3 larvae pass from the lung via
the trachea to the small intestine where they molt to L4 and develop
into sexually maturate adult worms in the small intestine [14].
Protein chemical analysis reveals that the change in complex II begins
with the anchor CybS subunit and then the Fp subunit [15].1.3. Parasite complex II
Complex II molecules are classiﬁed into four types (Type A–D) and
three classes (Class 1–3) according to the architecture of membrane
anchors and functions in vivo, respectively [16]. The membrane anchor
of Type A complex II consists of two polypeptide chains each having
three transmembrane helices and two protoheme IX (heme b) mole-
cules. Type B has one polypeptide chain with ﬁve transmembrane
helices and two heme b molecules. On the other hand, Type C and D,
like Type A, consist of two polypeptide chains with one and no heme
b molecules in their anchors, respectively. In addition, more recent
physiological analysis indicates novel Type E complex II [17], which is
different from Type A–D in membrane-anchoring subunits and the
composition of iron–sulfur centers. Class 1 complex II functions as
SQR in vivo and catalyzes the oxidation of succinate and the reduction
of high potential quinone, typically ubiquinone, whereas Class 2
complex II (QFR) catalyzes the opposite reaction, the oxidation of low
potential quinol such as menaquinol and rhodoquinol (RQH2) and the
reduction of fumarate. Complex II belonging to Class 3, like the Class 1
enzymes, exhibits SQR activity but reduces low potential quinone.
Crystal structures of complex II have been determined for three
QFRs from E. coli (pdb code, 1L0V; [18]),Wolinella succinogenes (1QLB;
[19]) and A. suum (3VR8; [20]), three SQRs from E. coli (1NEK; [21]),
porcine (1ZOY; [22]) and chicken (1YQ3; [23]). QFRs from E. coli,
W. succinogenes, and A. suum belong to Type D, Type B and Type C,t. Infective L3 larvae are ingested by the host, reach the small intestine and hatch there.
igrate back to the small intestine and develop into adults. In the host small intestine, the
life cycle, complex II molecules are expressed as stage-speciﬁc isoforms, larval-type,
Fig. 2. Overall structure ofA. suumQFR. (A) Cartoon representation of the overall structure
of A. suum QFR. FAD-binding subunit (Fp) is shown in green; iron–sulfur subunit (Ip) is
shown in cyan; and the transmembrane subunits CybL and CybS are shown in yellow
and orange, respectively. The intrinsic redox centers (FAD, [2Fe–2S], [4Fe–4S], [3Fe–4S]
and heme b) and bound small molecules (malonate, rhodoquinone, and lipid) are
shown as spheres. (B) The arrangement of the redox centers together with malonate,
rhodoquinone and lipid, and edge-to-edge distances between adjacent redox centers.
For calculation of edge-to-edge distances, the dominant determinants of the electron
tunneling rate, the sulfur atoms of the cysteine residues ligating to the iron–sulfur centers
are included as part of the redox centers. The FAD edge is the isoalloxazine ring system
and theheme edge is the conjugatedmacrocycle. Color-coding for each atom type is as fol-
lows: C, white; N, blue; O, red; S, dark yellow; and Fe, brown.
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Type C enzymes.
In general, the complex II molecules of helminthes, which are
multi-cellular parasites, are of Type C, although catalytic function
changes during the life cycle as mentioned above. However, complex
II puriﬁed from the parasitic protist, Trypanosoma cruzi, consists of
six hydrophilic and six hydrophobic nuclear-encoded subunits [24].
Notably, the iron–sulfur subunit is heterodimeric; SDH2N and SDH2C
contain plant-type ferredoxin domains in the N-terminal half and
bacterial ferredoxin domains in the C-terminal half, respectively.
In the case of malaria parasites, such as Plasmodium falciparum,
anchor subunits of complex II have not yet been identiﬁed, although
the enzyme shows SQR activity [25]. These unusual features of parasite
complex II molecules make them targets for new chemotherapeutic
agents.
In this review, we mainly focus on recent advances in the study of
A. suum complex II, which plays an important role in the anaerobic
energy metabolism of parasites. In addition, the molecular architecture
of 12 novel complex II subunits of T. cruziwill be discussed.
2. Structure of adult A. suum QFR
Anaerobic mitochondrial complex II from adult A. suum (A. suum
QFR) belongs to Type C/Class 2 and couples the oxidation of RQH2 to
RQ to the reduction of fumarate to succinate, an opposite reaction
catalyzed by SQR of the aerobic respiratory chain [7]. We crystallized
A. suum QFR in the presence of malonate [26], a well-known competi-
tive inhibitor against complex II in various organisms and determined
the crystal structure at 2.8 Å resolution (3VR8; [20]) by molecular re-
placement using the structure of porcine SQR (1ZOY; [22]) as the search
model. In addition, the structure of the ternary complex with fumarate
and ﬂutolanil was determined at 2.9 Å resolution (3VRB; [20]).
Flutolanil is a widely used commercially available fungicide [27] that
speciﬁcally inhibits A. suum QFR as shown by IC50 values for A. suum
QFR of 58 nM and porcine SQR of 46 μM. Based on these structures, as
well as the structure of porcine SQR in complex with ﬂutolanil (3AE8),
the enzymatic mechanism of A. suum QFR and the structural basis of
the speciﬁcity of ﬂutolanil against A. suum QFR will be discussed.
2.1. Overall structure
The structure of A. suum QFR, the ﬁrst eukaryotic Type C/Class 2
complex II molecule to be characterized, is composed of four protein
subunits (Fig. 2A): hydrophilic Fp (residues A33–A645) and Ip
(B33–B281) subunits, and membrane-anchoring hydrophobic CybL
(C34–C186) and CybS (D28–D156) subunits [20]. Several terminal
residues of each mature polypeptide (Fp: A31–A645, Ip: B29–B282,
CybL: C32–C188 and CybS: D26–D156) are missing in the current
model because of faint electron density. The enzyme accommodates
ﬁve prosthetic groups: a FAD molecule, three ion-sulfur centers
([2Fe–2S], [4Fe–4S], [3Fe–4S]), and one heme b molecule (Fig. 2B).
Although there are two molecules in the asymmetric unit, A. suum
QFR, like E. coli QFR [18], porcine SQR [22] and chicken SQR [23],
exists as a monomer both in solution and crystal, which distinguishes
the enzyme from the reported dimer structure of W. succinogenes QFR
[19] and the trimer structure of E. coli SQR [21]. Further, the amino
acid sequence of each subunit of A. suum QFR (Fig. 3) shows higher
identity with porcine and chicken SQRs than with E. coli SQR and
E. coli and W. succinogenes QFRs. Accordingly, A. suum QFR is more
closely related to porcine and chicken SQRs rather to E. coli and
W. succinogenes bacterial complex IIs. The arrangement of the bound
prosthetic groups in the A. suum QFR structure [20] is similar to that
of other complex IIs with known structures [18,19,21–23]. The chain
of the FAD, [2Fe–2S], [4Fe–4S] and [3Fe–4S] prosthetic groups is
disposed between dicarboxylate- and quinone-binding sites with
the distances between neighboring centers less than 14 Å (Fig. 2B),suggesting that electron transfer from RQH2 to FAD is carried out by
quantum tunneling [28], as proposed for E. coli SQR [21].2.2. Fp subunit
The largest Fp subunit of A. suum QFR [20] folds into four
domains (Fig. 4A): a FAD-binding domain (residues A33–A280 and
A380–A465), a capping domain (A281–A379), a helical domain
(A466–A568), and a C-terminal domain (A569–A645). The FAD
molecule forms a covalent bond with His A79 and hydrogen bonds
primarily with main-chain N atoms of highly conserved residues
of the FAD-binding domain (A49, A71, A72, A73, A78, A80, A84,
A85, A86, A201, A255, A421, A432, A437 and A438). In addition, res-
idues within 5 Å of the FAD group, especially those close to the FAD
isoalloxazine ring, are highly conserved (Fig. 3A).
Examination of the reﬁned structure shows signiﬁcant electron
density near the isoalloxazine ring that can be assigned as malonate,
an additive for crystallization [20]. The location of this site is in agree-
ment with the dicarboxylate-binding site assigned to other complex
IIs with known structures [18,19,21–23] and is constructed by resi-
dues of the FAD-binding domain (A84, A85, A153, A276, A387, A432
and A435) and the capping domain (A286, A288, A289 and A320).
Three basic residues, Arg A320, His A387 and Arg A432, interact
with the C3 carboxylate group of the bound malonate, and Thr A288
and Arg A320 with the C1 carboxylate group (Fig. 4A). With the
exception of A84, A153 and A435, these residues are conserved across
complex II molecules with known structures (Fig. 3A).
Fig. 3. Amino acid sequences of A. suum SQR. (A) Fp, (B) Ip, (C) CybL, and (D) CybS subunits. Residues conserved in the six complex II molecules with known structures (SQRs from
porcine, chicken, and E. coli and QFRs from E. coli,W. succinogenes, and A. suum) are highlighted in red, residues conserved in SQRs from porcine, chicken, and E. coli and A. suum QFR
are highlighted in green, residues conserved in porcine and chicken SQRs and A. suum QFR are highlighted in blue. Residues within 5 Å of FAD, [2Fe–2S], [4Fe–4S], [3Fe–4S],
rhodoquinone and heme b redox centers are marked by *, 2, 4, 3, q, and h, respectively.
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The Ip subunit (Fig. 4B) is constructed by two domains, a plant
ferredoxin-like N-terminal (B33–B130) and a bacterial ferredoxin-like
C-terminal (B131–B281) domain [20]. The [2Fe–2S] center is bound to
the N-terminal domain through coordination bonds with four cysteine
residues (B89, B94, B97, and B109). The [4Fe–4S] and [3Fe–4S] centers
are bound to the C-terminal domain and are coordinated by four
(B182, B185, B188, and B249) and three (B192, B239, and B245) cyste-
ine residues, respectively. Except for Cys B97, which is replaced by
aspartate (Asp B63) in E. coli SQR [21], the cysteine residues are con-
served (Fig. 3B). Out of 47 residues located within 5 Å of the iron–sulfur
center of A. suum QFR [20], 44 residues are conserved in porcine and
chicken SQRs, but that number decreases to 20 residueswhen compared
across all complex II molecules with known structures [18,19,21–23].
The sulfur atoms of the cysteine ligands of [2Fe–2S] and [4Fe–4S]
form –S:⋅⋅⋅⋅H–Nb interactions with main-chain amino groups of theN-terminal domain (B91, B92, B93, B96, and B108) and C-terminal
domain (B184, B186, B187, B189, and B251), respectively. In addition,
sulfur atoms of the iron–sulfur centers interact with the Ip subunit: the
[2Fe–2S] center interacts with B90 N and B95 N, the [4Fe–4S] center
with B183 N and B186 N, and the [3Fe–4S] center with B243 N. The
–S:⋅⋅⋅H–Nb interaction is also found in other complex II molecules
[18, 19, 21–23, pdb code: 1L0V, 1QLB, 1NEK, 1ZOY and 1YQ3] and
could affect the basicity of sulfur atoms of the cysteine ligands and the
redox centers. It is worth noting that side chain atoms of Ser B96, Cys
B187, and Tyr B202 interact with sulfur atoms of Cys B94, Cys B185,
and [3Fe–4S], respectively (Fig. 4B). Although these residues are con-
served in porcine and chicken complex II molecules (Fig. 3), Cys B187
is replaced by Leu in E. coli QFR, and Tyr B202 is replaced by Phe in
E. coli and W. succinogenes QFRs and E. coli SQR. Therefore, A. suum
QFR is more similar to mitochondrial porcine and chicken SQRs than
bacterial complex II molecules with respect to the environment of the
iron–sulfur centers.
Fig. 4. Depiction of subunits. (A) Cartoon representation of the Fp subunit. The FAD-binding domain, capping domain, helical domain and C-terminal domain are shown in pale
green, light blue, light pink and white, respectively, together with the stick models of FAD and malonate. The close-up view of the neighborhood of FAD is also represented in
the inset. Color-coding for each atom type: C, white; N, blue; and O, red. Carbon atoms of residues from the FAD-binding domain and capping domain are shown in pale green
and light blue, respectively. (B) Cartoon representation of the N-terminal domain (cyan) and C-terminal domain (light blue) of the Ip subunit together with the iron–sulfur centers
shown as stick models. The close-up view of the iron–sulfur centers, cysteine ligands and residues interacting with the centers are shown in the insets. In (A) and (B), hydrogen
bonds are shown with dashed lines. (C) Cartoon representation of the membrane-anchoring CybL (yellow) and CybS (orange) subunits together with heme b and the bound
lipid molecule viewed from orientations perpendicular to each other. C131 and D95 are histidine residues from CybL and CybS subunits, respectively.
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The membrane anchor of A. suum QFR, like E. coli, porcine and
chicken SQRs [21–23], is made up of CybL and CybS subunits. They
are composed of ﬁve (CybL: αL1–αL5) and four (CybS: αS1–αS4)
α-helices, of which αL2, αL4, αL5, αS1, αS2, and αS3 are transmem-
brane helices [20]. Four helices, αL2, αL4, αS1, and αS2, form a helix
bundle in which a heme b molecule is accommodated through
ligation of conserved His C131 and His D95 (Fig. 4C). Unlike the
FAD molecule and the iron–sulfur centers, most residues near the
heme b molecule are not conserved (Fig. 3C and D). A lipid molecule
is bound below the heme b site in the helix bundle. Phosphatidyleth-
anolamine is incorporated into the current model, although electron
density patterns are not clear enough to identify the lipid species.
Both heme b and lipid molecules are located at the interface of CybL
and CybS subunits and may contribute to the assembly of the CybL
and CybS subunits. Interestingly, a segment comprising 27N-terminal
residues (D28–D54, Fig. 4C) of the CybS subunit extends to the
Fp and Ip subunits and ﬁve residues (D29, D39, D41, D42, D46)
form inter-subunit hydrogen bonds with residues of Fp (A471, A195,
A192) and Ip (B150). The segment is unique to A. suum QFR, and
seems to contribute to the stabilization of the multi-subunit structure
of the enzyme. A deﬁnite cleft is formed at the interface of the
Ip, CybL, and CybS subunits, and residual electron density probably
revealing a bound RQ molecule is found in the cleft. The location of the
cleft is in agreement with the quinone-binding sites assigned in the
structures of other complex II molecules [18,21–23]. In the reﬁned struc-
ture (3VR8), RQ is well situated in the cleft (Fig. 2) and is surrounded by
residues that are highly conserved among complex II molecules from
porcine, chicken and A. suum (Fig. 3C and D).
2.5. Mechanisms of fumarate reduction and rhodoquinol oxidization
The crystal structure of the fumarate-bound A. suum QFR (3VRB)
clearly reveals that a fumarate molecule is bound to the dicarboxylate
site in a non-planar conformation (Fig. 5A); C2, C3, and C4 carboxyl
groups are in the same plane parallel to the FAD isoalloxazine ring
but the C1 carboxyl group deviates from the plane as indicated by a
C3–C2–C1–O1A dihedral angle of 83.7°. The non-planar conformation
is stabilized by hydrogen bonds with conserved residues; the C1 car-
boxyl group with Gly A85, His A276, Thr A288, and Glu A289, and the
C4 carboxyl group with Arg A320, His A387, Arg A432, and Ala A435.
Accordingly, the structure suggests that the uniform distribution
of π-electrons over the conjugated double bonds of fumarate is
disrupted and that a partial charge separation, C2δ+ and C3δ−, is
induced on the bound fumarate molecule. This charge separation
seems to be the key to the reduction of fumarate because the contact
of C2δ+with FADN5 (3.5 Å) observed in the crystal structure should fa-
cilitate the hydride (or hydride equivalent) transfer from reduced FAD
N5 to C2δ+. The twisted conformation of fumarate is also observed in
E. coli [29] and W. succinogenes [19] QFRs, as well as in ﬂavoproteins
such as ﬂavocytochrome c [30] and T. cruzi dihydroorotate dehydroge-
nase [31], and the similar mechanism of fumarate reduction has been
proposed for these enzymes. The crystal structure also suggests that
conserved Arg A320 probably supplies a proton to C3δ− to complete
the fumarate reduction.
Fig. 5B shows the RQ binding site of A. suum QFR. Of 12 residues
within 5 Å of the bound RQ, nine residues (B193, B194, B197, B240,
B242, C72, C76, D106, and D107) are conserved in porcine, chicken,
and E. coli SQRs (Fig. 3). The [3Fe–4S] center, the nearest iron–sulfur
center to the bound RQ, is located at distances of 9.1 and 7.7 Å from
RQ O1 and O2, respectively, indicating that electrons are transferred
from RQH2 to FAD via the [3Fe–4S], [4Fe–4S], and [2Fe–2S] centers.
Although residues surrounding heme b are mostly not conserved
among complex II molecules (Fig. 3), the possibility of heme b to act
as an electron acceptor from RQH2 remains because heme b is alsothe redox center close to the bound RQ (Fig. 2B) and its redox poten-
tial (−34 mV, [16]) is higher than that of RQH2 (−63 mV). RQ is also
surrounded by conserved amino acid residues in SQRs from porcine,
chicken and E. coli (Ser C72, Arg C76, Asp D106, and Tyr D107) and
is involved in these hydrogen bond networks: RQ O1⋅⋅⋅⋅Tyr
D107⋅⋅⋅⋅Arg C76⋅⋅⋅⋅Asp D106 and RQ O2⋅⋅⋅⋅Ser C72⋅⋅⋅⋅RQ N⋅⋅⋅⋅Arg
C76⋅⋅⋅⋅Asp D106. Protons abstracted from RQH2 can leave along
these networks. It should be noted that the amino group of RQ,
which is replaced by the methoxy group in ubiquinone, is involved
in one of the hydrogen bond networks.
2.6. Flutolanil-binding site
In both crystal structures of A. suumQFR (Fig. 6A, 3VRB) and porcine
SQR (Fig. 6B, 3AE8) complexed with ﬂutolanil, an inhibitor speciﬁc for
A. suumQFR [26], ﬂutolanil is bound to the quinone-binding site located
near the [3Fe–4S] center (Qp site), where residues of A. suum QFR and
porcine SQR within 5 Å of the bound ﬂutolanil are mostly identical
(73%). The isopropoxy-phenyl moiety of ﬂutolanil comes in contact
with conserved hydrophobic residues and the carbonyl oxygen forms
hydrogen bonds with tyrosine and tryptophan residues. Accordingly,
these hydrogen bonds as well as van der Waals contact seem to be
important for the binding of ﬂutolanil to both enzymes. It is worth
noting that there is close contact between the isopropoxy group of the
bound ﬂutolanil and the aromatic indole ring of A. suum QFR Trp C69;
these are separated by 3.3 Å, signiﬁcantly less than the distance
expected for van derWaals contact (3.7 Å), indicating that they interact
with each other through a C–H⋅⋅⋅⋅π interaction. Since the tryptophan
residue is replaced by methionine (Met C39) in porcine SQR, this elec-
trostatic interaction is unique to A. suum QFR. Another electrostatic
interaction unique to A. suum QFR is formed between the ﬂutolanil
triﬂuoromethylbenzene moiety and Arg C76 guanidino group. Since
the triﬂuoromethyl group is an electron-withdrawing group, the
π-orbital of the ﬂutolanil aromatic ring is expected to be deﬁcient in
electrons. In contrast, the π-orbital of the guanidino group of Arg C76
seems to be rich in electrons because the arginine residue located in
the hydrophobic environment of the membrane-anchoring CybL
subunit may preferentially the unprotonated form over the protonated
one. Therefore, the stacking of the two π-orbitals, one is deﬁcient and
another rich in electron, with the distance of 3.2 Å observed in the
A. suum QFR-ﬂutolanil complex reinforce the attractive interaction
between ﬂutolanil and A. suum QFR. In porcine SQR, however, the
guanidino group of Arg C46, the counterpart residue to Arg C76, is a
greater distance from the ﬂutolanil triﬂuoromethylbenzene moiety
and is poorly stacked.
In contrast to ﬂutolanil, 2-thenoyltriﬂuoroacetone (TTFA), a potent
inhibitor against mammalian SQR, does not inhibit both A. suum QFR
and SQR [11]. There are two TTFA binding sites in porcine SQR [22], Qp
andQd sites. TheQp site TTFA, likeﬂutolanil bound to theQp site, accepts
hydrogen bonds and van der Waals contacts from residues that, except
for Trp C35 (Pro C65 in A. suum enzymes), are conserved in the A. suum
enzymes, whereas the Qd site TTFA is surrounded mostly by residues
unconserved in the A. suum enzymes and interacts with porcine SQR
mainly through water molecules [22]. Therefore, if it is assumed that
the Qp site is more crucial for the inhibition of complex II than the Qd
site, the insensitivity of A. suum enzymes toward TTFA may be caused
by the change from Trp C35 to Pro C65.
3. Twelve novel subunits of T. cruzi complex II
3.1. Subunit structure of T. cruzi complex II
The parasitic protist T. cruzi is the etiological agent of Chagas
disease, a public health threat in Central and South America. These
parasites are normally transmitted by the reduviid bug via vector
feces after a bug bite and are also transferred via transfusion of infected
Fig. 5. Close-up view of active site structures. (A) The fumarate molecule bound to the dicarboxylate-binding site of A. suum QFR and residues interact with fumarate. Hydrogen
bonds are shown in yellow dashed lines. Red dashed lines indicate probable routes of hydride (FAD N5→ fumarate C2δ+) and proton (Arg A320 Nη→C3δ−) transfers to reduce
fumarate. (B) Rhodoquinol binding site of A. suum QFR. Hydrogen bonds are shown in yellow dashed lines. Color-coding for each atom type is as follows: N, blue; O, red; S, dark
yellow; and Fe, brown. Carbon atoms of FAD, RQ and heme b are shown in white, residues from Fp, CybL and CybS are shown in light green, yellow, and orange, respectively.
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risk, but there are no deﬁnitive chemotherapeutic treatments available
[32].
To our surprise, the complex II puriﬁed from T. cruzi consists of six
hydrophilic (SDH1, SDH2N, SDH2C, and SDH5–SDH7) and six hydropho-
bic (SDH3, SDH4, and SDH8–SDH11) nuclear-encoded subunits (Fig. 7;
[24]). SDH1 and SDH2 correspond to Fp (SDHA) and Ip (SDHB), respec-
tively. Orthologous genes for each subunit were identiﬁed in most
trypanosomatids, including T. brucei and Leishmania major [33–35].
Notably, the iron–sulfur subunit was heterodimeric; SDHBN and SDHBC
contain the plant-type ferredoxin domain in the N-terminal half and
the bacterial ferredoxin domain in the C-terminal half, respectively.
Catalytic subunits (SDHA, SDHBN plus SDHBC, SDH3, and SDH4) contain
all key residues for binding of dicarboxylates and quinones, but the
enzyme showed lower afﬁnity for both substrates and inhibitors than
mammalian enzymes. In addition, the enzyme binds protoheme IX, but
SDH3 lacks a histidine ligand [24].
3.2. Split Ip subunit of Trypanosomal complex II
In contrast to the monomeric iron–sulfur subunit (SDHB) found in
all known families of complex II, the Trypanosomal iron–sulfur
subunit is composed of two nuclear-encoded genes for SDHBN and
SDHBC subunits (Fig. 7) [24]. The crystal structure of the Ip subunit
from porcine complex II [22] and the PHYRE2 model [36] of T. cruzi
SDHBN (residues BN66 to BN161) and SDHBC (residues BC34 to BC163)
are shown in Fig. 8A and B, respectively. The C-terminal extension
of TcSDHBN (residues BN162 to BN270) was removed from the model
to allow better comparison between porcine Ip (Fig. 8A) and split
Trypanosomal Ip (Fig. 8B) subunits. According to this model, the
[2Fe–2S] center is bound to the TcSDHBN subunit (Fig. 8B) by four
cysteine residues, BN120, BN125, BN128, and BN140 (Fig. 9), which
correspond to cysteine residues B65, B70, B73, and B85 from porcine
SDHB [22]. The [4Fe–4S] center is bound to TcSDHBC by cysteine resi-
dues BC71, BC74, BC77, and BC138 (Fig. 9), which correspond to cysteine
residues B158, B161, B164, and B225 from the porcine SDHB subunit
and, ﬁnally, the [3Fe–4S] center is bound by cysteine residues BC81,BC128, and BC134 (Fig. 9), which correspond to cysteine residues
B168, B215, and B221 from porcine SDHB subunit [22]. The residues
from SDHB subunit which interact with ﬂutolanil from porcine complex
II (B216, B218, B169, and B173 from Fig. 4B) are also found in TcSDHBC
(BC82, BC86, BC129, and BC131 in Fig. 9). Thus, even if the Ip subunit of
the Trypanosomatid complex II is comprised of two distinct peptides,
the three iron–sulfur clusters as well as all cysteine residues necessary
to bind those clusters are structurally conserved among all families of
complex II. Such spatial organization of iron–sulfur clusters is expected
to be crucial for optimal electron transfer from succinate to ubiquinone.
3.3. T. cruzi complex II as a drug target
Puriﬁed T. cruzi enzyme shows reduced binding afﬁnities for both
substrates and inhibitors. Its Km values for ubiquinone (18.8±6.4 μM
(Q2)) and succinate (1.48±0.17 mM) were higher than those with bo-
vine enzyme [37] (0.3 and 130 μM, respectively) and E. coli enzyme
[38,13] (2 and 277 μM, respectively). Interestingly, the T. cruzi enzyme
Km value for succinate was comparable to 610 μM in adult A. suum
[10], which expresses the stage-speciﬁc complex II as QFR under hypoxic
environments in the host organisms mentioned above.
Sensitivity to inhibitors also differs from that of other complex II
molecules. Atpenin A5, a potent inhibitor for complex II, inhibited
the T. cruzi enzyme with an IC50 value of 6.4±2.4 μM, which is
three orders of magnitude higher than that of bovine enzyme
(4 nM) [39]. Furthermore, T. cruzi enzyme does not respond to
carboxin, 2-theonyltriﬂuoroacetone (TTFA), plumbagin, and 2-heptyl-
4-hydroxyquinoline N-oxide (HQNO) (100 μMb IC50). Structural diver-
gence in Trypanosomatid SDH3 and SDH4 could be the cause for
lower binding afﬁnities for both quinones and inhibitors. In addition,
the IC50 for malonate (40 μM) was much higher than the Ki value for
bovine complex II (1.3 μM) [37], indicating different structures of the
dicarboxylate-binding site.
These unusual features are unique in Trypanosomatidae and make
their complex II molecules a target for new chemotherapeutic agents.
Insensitivity to a known inhibitor is a promising feature for identify-
ing a speciﬁc and potent inhibitor. Ascofuranone, which is a most
Fig. 6. Flutolanil binding site. The structures of ﬂutolanil binding sites of (A) A. suum QFR and (B) porcine SQR. In each structure, the ﬂutolanil molecule is bound to the
quinone-binding site and surrounded by residues from Ip (cyan), CybL (yellow), and CybS (orange) subunits. Most of these residues are conserved between the two enzymes.
Close-up views of the C―H⋅⋅⋅⋅⋅π interaction between the isopropoxy group of ﬂutolanil and Trp C69 side chain, and the electrostatic interaction between the ﬂutolanil
triﬂuoromethylbenzene moiety and Arg C76 guanidino group are shown in insets. Hydrogen bonds are shown in yellow dashed lines.
Fig. 7. Subunit organization model of Trypanosomal complex II. The Trypanosomal com-
plex II is composed of six hydrophilic subunits (SDHA/BN/BC/E–G) and six hydrophobic
subunits (SDHC/D/H–K). In the case of Trypanosomal complex II, the canonical SDHB is
split into SDHBN (pink) and SDHBC (blue).
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is good example [40].
4. Perspectives and conclusion
As described above, parasites have exploited a variety of energy-
transducing systems in their adaptation to speciﬁc environments
inside their hosts. Dynamic rearrangement of the respiratory chain
during the life cycle is one of the key elements of this adaptation.
However, the control mechanism responsible for stage-speciﬁc
expression of the genes of parasites remains unclear because research
on parasites at the molecular level has only recently begun. In this
regard, recent reports indicating that complex II functions as an
oxygen sensor are of great interest [41]. Mammalian cells are able
to sense decreased oxygen availability and activate response systems,
including transcriptional activation of several genes controlled via
hypoxia-inducible factor-1 (HIF-1) [42]. Although the molecular
mechanism of gene expression has not been elucidated for parasites,
A. suum shows a very clear transition of the metabolic systems
between larvae and adult stages, and it is, thus, a very promising
research model. Our recent results show that a HIF-1 homologue
plays a role in oxygen adaptation in A. suum and sequence analysis
Fig. 8. PHYRE2 model of split T. cruzi SDHB subunits. Superposition of porcine SDHB crystal structure (green, residues Pro B9 to Glu B237) (A), with the PHYRE2 model of T. cruzi
SDHBN (pink, residues Thr BN66 to Asp BN161) and SDHBC (blue, residues Val BC34 to Pro BC163) subunits (B). All cysteine residues coordinating with the Fe–S clusters are
conserved and represented as stick, while iron (orange) and sulfur (yellow) clusters as spheres. The C-terminal residues from BN162 to BN270 of TcSDHBN were removed from
the PHYRE2 model for ease of comparison between porcine and T. cruzi SDHB subunits.
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hypoxia-responsive element (HREs), suggesting that HIF-1 directly
regulates the expression of stage-speciﬁc complex II isoforms [43].
Diversity of complex II is found not only in parasites but also in
human host. Two isoforms of human Fp, type I and type II, were
reported [44,45]. These isoforms differed from each other only in two
amino acid residues: Tyr 586 and Val 614 of type I Fp are replaced by
Phe 586 and Ile 614 in type II Fp, respectively. Type I Fp are well
conserved among the Fp of mammals, and type II Fp is found only in
human complex II. Although the type I Fp gene is located on chromo-
some 5p15 and has an exon–intron structure [44,46], the type II Fp
gene is not found in the NCBI database. Baysal et al. suggested that
type II Fp is a variant of the Fp subunit and can be explained by
balancing selection over the long term [47]. Interestingly, expression
of type II Fp mRNA is increased in normal cells cultured under ischemic
conditions [48]. It is of interest to speculate that complex IIII has higher
QFR activity and plays an important role in fumarate respiration in
human mitochondria as the terminal oxidase of the system similar to
that in A. suum adult complex II. Anti-cancer activity of pyrvinium
pamoate an anthelmintic, which is a known fumarate reductase inhibi-
tor, against human cancer cells should be studied further [49]. The
diversity of mitochondrial complex II molecules lends itself to studiesFig. 9. All cysteines necessary for binding Fe–S clusters are conserved in Trypanosomal
split Ip subunits. Cysteine residues from SDHBN are colored and labeled in pink and
residues from SDHBC are in blue. The equivalent residues from Trypanosomal SDHBC,
which were found to interact with ﬂutolanil from porcine SDHB are labeled in red.
The three iron (orange) and sulfur (yellow) clusters are represented as spheres.in many areas, including bioenergetics, molecular evolution and drug
discovery.
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